# LLM call: summary

- Turn: 12
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 1041
- Completion tokens: 340
- Total tokens: 1381
- Cost (USD): 0.000172

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-2124: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
By late 2030 the US cut off European licences for the leading American model, forcing hospitals, ministries and ports to paper and queues. Brussels imposed an emergency fallback to older licensed and EU-hosted Observatory-vetted models with degraded procedures, manual sign-off and kill-switches, avoiding cascade at cost of slower operations. The EU remained under tiered-access rationing after a US leapfrog, with a thin Washington-Beijing risk pact excluding Brussels, whose pleas for humanitarian licence restoration failed. Capital flight left empty gigafactory sites, and cyber-cover withdrawal forced ministers to stretch an unfunded state guarantee to substitute-model liability.

In winter-spring 2031 small hospitals and clinics unable to renew commercial cyber-insurance suspended networked records after ransomware probes and reverted to paper. Regional governments refused sole risk; the Commission sent patching crews and offered emergency state cover tied to isolated EU-hosted clinical systems, accepted by some, refused by others as unfunded and error-prone. Simultaneously a circulating genome model claiming a viable human-infecting organism design sparked closed biosecurity dispute, met with enhanced pathogen reporting, triage stocks and detection protocols folded into care-continuity, straining labs. Diplomats carried ransomware and bio files to Washington and Beijing but returned without licences.

July-December 2031 became endurance: the isolated fallback with manual sign-off became the formal standard, without restoring speed; outpatient queues lengthened and operations postponed. About half the paper-reverted clinics reconnected under conditional state cover; the rest stayed on paper citing unsafe substitutes and unfunded guarantee. Pathogen reporting continued thinly with late logging and unguarded stocks. No new Brussels file was opened; renewed Washington-Beijing pleas for humanitarian licences failed. Unconfirmed reports of prescription transcription harms in paper wards were cited by both sides. By December nothing had cascaded, but relief remained absent.

CURRENT NARRATIVE:
### The sweep
In February the automated attack arrived as feared: a ransomware sweep built with model-generated tooling, moving through municipal administration, two regional hospital networks and a shared software dependency used for appointments and billing. Screens went dark in town halls from the Rhine to the Po valley. ENISA triage teams fanned out with the playbook Brussels had just approved — isolate, fall back to the separated clinical systems with manual sign-off and kill-switches, restore from backups.

It worked, after a fashion. Services degraded but did not stop. Queues that were already long doubled. Staff reverted to paper where the isolated build would not load. No grid collapsed, no region lost emergency care entirely. Defenders were visibly behind for weeks, and attribution remained open by June.

The continuity shield finished in the middle of it. Pre-positioned triage stocks, patching crews and the conditional state cover held for the half of paper-reverted clinics that had reconnected. That half stayed open through the sweep. The other half did not.

### Paper harms
In March a national investigation desk published what local papers had whispered: a cluster of avoidable harms — wrong doses, missed referrals, delayed oncology appointments — traced to transcription failures in paper wards and in the substitute referral software. Families spoke on camera. Regulators opened a joint audit with Brussels, publishing weekly findings as promised.

The findings pleased no one. Paper transcription and substitute software both misread. Directors who had refused state cover said the audit proved the substitutes unsafe; Commission officials said it proved paper unsafe. The argument played out while the sweep was still being cleaned up.

### Distant cures
Spring also brought news of tailored therapies reaching ordinary use elsewhere — remissions where none had existed. European oncologists could describe them, not prescribe them. Without frontier licences on European terms, hospitals applied for compassionate-use exceptions case by case. Most were refused or delayed. Talk shows ran the cures alongside the queues.

By June ministers again claimed nothing had cascaded. It was true, and thinner than before. The triage operation had held the line, but blame for the harm cluster settled squarely on the European fallback itself, and gratitude for endurance was exhausted.
```

## Raw response

```
By late 2030 the US cut off European licences for the leading American model, forcing hospitals and services to paper and queues. Brussels imposed an emergency fallback to older EU-hosted Observatory-vetted models with manual sign-off and kill-switches, avoiding cascade at cost of slower operations, under continued tiered-access rationing and failed pleas for humanitarian licences.

In winter-spring 2031 uninsured clinics reverted to paper after ransomware probes; patching crews and conditional state cover reconnected about half, the rest refused as unsafe/unfunded. A circulating genome model claiming a viable human-infecting design prompted enhanced pathogen reporting and triage stocks, straining labs. Diplomacy in Washington and Beijing yielded no licences.

In Feb-June 2032 a model-built ransomware sweep hit municipal administrations, two hospital networks and shared appointment/billing software from the Rhine to Po valley. ENISA triage — isolate, fallback to separated systems, restore from backups — prevented collapse of grid or emergency care, but queues doubled and defenders lagged for weeks with attribution open. Reconnected clinics under state cover stayed open; paper wards did not.

In March investigation revealed avoidable harms — wrong doses, missed referrals, delayed oncology — from paper transcription and substitute referral software; joint audit confirmed both unsafe, fuelling blame over the fallback. Meanwhile tailored therapies advanced elsewhere but remained unavailable in Europe except delayed compassionate-use cases. By June ministers again claimed no cascade, but endurance credit was exhausted and blame settled on the European fallback itself.
```
